필터링

체재

모든

모든
비디오
임상적 특징

정렬

최신

최신
가장 오래된

대사질환

Empagliflozin (자디앙®)
Linagliptin(트라젠타)

/kr/metabolic/empagliflozin/prof-merlin-thomas-nephrologist

20:49

Prof. Merlin Thomas (Nephrologist)

/kr/metabolic/empagliflozin/prescribing-information/jardiance-duo-prescribing-information

자디앙 듀오 처방 상세 정보(PI)

/kr/metabolic/empagliflozin/prescribing-information/jardiance-prescribing-information

자디앙 처방 상세 정보(PI)

/kr/metabolic/empagliflozin/clinical-study-results/empa-reg-outcome-study-result

EMPA-REG OUTCOME 연구 결과

/kr/metabolic/empagliflozin/efficacy/what-leading-cause-death-patients-type-2-diabetes

01:35

제2형 당뇨 환자의 주요 사망 요인

/kr/metabolic/empagliflozin/efficacy/demonstrating-cardiovascular-benefit-empagliflozin-jardiance

02:56

자디앙 심혈관 이점 소개

/kr/metabolic/empagliflozin/efficacy/management-type-2-diabetes-treatment-considerations

02:46

제2형 당뇨 관리 – 치료 고려 요인

/kr/metabolic/empagliflozin/efficacy/management-cv-risk-patients-t2d

02:22

제2형 당뇨 환자의 심혈관계 위험 관리

/kr/metabolic/linagliptin/cvot/carolina-key-summary-and-implication

01:58

Short summary

/kr/metabolic/linagliptin/cvot/carmelina-key-summary-and-implication

01:39

Short summary

/kr/metabolic/linagliptin/cvot/key-summary-and-implication

01:31

Short summary

종양학

Afatinib(지오트립)

/kr/oncology/giotrif/efficacy/medical-treatment-options-patients

04:16

Medical Treatment Options for Patients with EGFR M+ NSCLC suffering from Brain Metastases and/or Leptomeningeal Disease

/kr/oncology/giotrif/sequencing/how-far-you-consider-extending-chemotherapy

02:13

How far you consider extending the chemotherapy-free length of treatment?

/kr/oncology/giotrif/sequencing/consider-evidencereal-world

Consider evidence from the real world in deciding the optimal treatment sequence

/kr/oncology/giotrif/sequencing/optimizing-survival-outcomes-which-tki-and-when

01:22

Optimizing survival outcomes : Which TKI and When?

/kr/oncology/giotrif/efficacy/giotrif-showed-comparable-pfs

GIOTRIF® showed comparable PFS in Real world Evidence

/kr/oncology/giotrif/efficacy/impact-giotrif-dose-modification

Impact of GIOTRIF® dose modification on safety and effectiveness in patients with EGFR M+ NSCLC

/kr/oncology/giotrif/prescribing-information

Full PI

호흡기

Tiotropium & Olodaterol(바헬바 레스피맷)

/content/optimizing-inhaler-choice

3:05

Optimizing Inhaler Choice

/kr/respiratory/spiolto/respimat/suction-power-and-paradox-copd-devices

03:37

흡입력과 COPD 디바이스의 역설

/kr/respiratory/spiolto/prescribing-information-details

스피리바 처방 상세 정보 (PI)

/kr/respiratory/spiolto/respimat/how-assemble

01:15

레스피맷의 조립/사용방법

/kr/respiratory/spiolto/respimat/importance-particle-size

01:12

레스피맷의 우수한 폐 침착률

/kr/respiratory/spiolto/respimat/vahelva-respimat-instruction

03:40

바헬바 사용방법 동영상

/kr/respiratory/spiolto/prescribing-information

바헬바PI